ENDPOINTS

Formation Bio’s up to €545M licensing deal with Sanofi; Otsuka, Harbour BioMed team up

Plus, news about Incyte, Carisma Therapeutics, Idorsia, Leap Therapeutics, Enterome, Merck, Forte Biosciences, Enzon and Viskase: Formation Bio licenses JAK/SYK inhibitor to Sanofi: The startup said the deal could be worth ...

Jun 23, 2025 - 16:20
 0
Formation Bio’s up to €545M licensing deal with Sanofi; Otsuka, Harbour BioMed team up
Plus, news about Incyte, Carisma Therapeutics, Idorsia, Leap Therapeutics, Enterome, Merck, Forte Biosciences, Enzon and Viskase: Formation Bio licenses JAK/SYK inhibitor to Sanofi: The startup said the deal could be worth ...
Read More

Tags:

Previous Article

Freak wind gusts made worse by climate change threaten airline passenger safety

Next Article

Why is Iran’s nuclear programme so essential to its identity?

Related Posts

Acting CDER chief to depart FDA in July

Acting CDER chief to depart FDA in July

Jun 23, 2025  0

FDA chief Makary says he wasn’t involved in decision to fire ACIP members

FDA chief Makary says he wasn’t involved in decision to...

Jun 10, 2025  0

Two new ACIP picks were paid experts against Merck in court

Two new ACIP picks were paid experts against Merck in c...

Jun 12, 2025  0